Carla De Giovanni

occupation: researcher

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 38

Date

Title

Authors

2021-11-13

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression

Carla De Giovanni, Patrizia Nanni, Arianna Palladini, Pier-Luigi Lollini, Marianna L Ianzano, Raffaele A. Calogero, Lorena Landuzzi, Giordano Nicoletti, Francesca Ruzzi, Verónica Celeste De Giusti, Roberta Laranga
2019-02-07

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis

Carla De Giovanni, Patrizia Nanni, Lorena Landuzzi, Marianna L Ianzano, Giordano Nicoletti, Stefania Croci, Arianna Palladini, Pier-Luigi Lollini
2019-04-11

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R

Arianna Palladini, Patrizia Nanni, Pier-Luigi Lollini, Carla De Giovanni, Augusto Amici, Stefania Croci, Lorena Landuzzi, Giordano Nicoletti, Francesca Ruzzi, Marianna Lucia Ianzano
2018-06-11

OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis

Patrizia Nanni, Giordano Nicoletti, Lorena Landuzzi, Arianna Palladini, Mario Paolo Colombo, Pier-Luigi Lollini, Carla De Giovanni, Marianna Lucia Ianzano
2014-01-23

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

Elena Quaglino, Lorena Landuzzi, Massimiliano Dall'ora, Stefania Croci, Manuela Iezzi, Federica Cavallo, Patrizia Nanni, Pier-Luigi Lollini, Giordano Nicoletti, Carla De Giovanni, Arianna Palladini, Valentina Grosso, Roberta Laranga, Marianna Lucia Ianzano, Augusto Amici
2013-01-31

Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus

Patrizia Nanni, Valentina Gatta, Massimiliano Dall'ora, Stefania Croci, Lorena Landuzzi, Manuela Iezzi, Gabriella Campadelli-Fiume, Pier-Luigi Lollini, Marianna L Ianzano, Giordano Nicoletti, Carla De Giovanni, Arianna Palladini, Valentina Grosso, Laura Menotti
2013-06-10

Preclinical HER-2 Vaccines: From Rodent to Human HER-2

Patrizia Nanni, Pier-Luigi Lollini, Carla De Giovanni
2013-12-01

Preclinical vaccines against mammary carcinoma

Pier-Luigi Lollini, Federica Cavallo, Patrizia Nanni, Carla De Giovanni
2013-10-24

Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment

Patrizia Nanni, Pier-Luigi Lollini, Mariantonietta Capristo, Valentina Giorgio, Ivana Kurelac, Luisa Iommarini, Michela Rugolo, Valerio Carelli, Carla De Giovanni, Anna Ghelli, Anna Maria Porcelli
2012-06-21

Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor

Patrizia Nanni, Stefania Croci, Agnese Antognoli, Alessia Lamolinara, Manuela Iezzi, Pier-Luigi Lollini, Marianna L Ianzano, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Annalisa Murgo, Arianna Palladini, Valeria Stivani, Valentina Grosso
2012-07-01

The molecular basis of herpesviruses as oncolytic agents

Patrizia Nanni, Pier-Luigi Lollini, Gabriella Campadelli-Fiume, Carla De Giovanni, Laura Menotti
2011-12-01

Vaccines and other immunological approaches for cancer immunoprevention

Patrizia Nanni, Federica Cavallo, Pier-Luigi Lollini, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni
2011-05-27

Rethinking herpes simplex virus: the way to oncolytic agents

Patrizia Nanni, Pier-Luigi Lollini, Gabriella Campadelli-Fiume, Carla De Giovanni, Laura Menotti
2011-08-18

A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function

Patrizia Nanni, Pier-Luigi Lollini, Ivana Kurelac, Mariantonietta Capristo, Luisa Iommarini, Claudio Ceccarelli, Katia Scotlandi, Valerio Carelli, Michela Rugolo, Giordano Nicoletti, Carla De Giovanni, Anna Ghelli, Anna Maria Porcelli
2011-01-26

2011: the immune hallmarks of cancer

Federica Cavallo, Patrizia Nanni, Pier-Luigi Lollini, Carla De Giovanni
2011-05-11

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines

Patrizia Nanni, Pier-Luigi Lollini, Agnese Antognoli, Stefania Croci, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Annalisa Murgo, Arianna Palladini, Valeria Stivani, Valentina Grosso, Marianna Lucia Ianzano
2010-10-05

In silico modeling and in vivo efficacy of cancer-preventive vaccinations

Agnese Antognoli, Stefania Croci, Lorena Landuzzi, Patrizia Nanni, Santo Motta, Pier-Luigi Lollini, Marianna L Ianzano, Giordano Nicoletti, Carla De Giovanni, Annalisa Murgo, Arianna Palladini, Valeria Stivani, Valentina Grosso, Francesco Pappalardo
2010-11-01

Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system

Patrizia Nanni, Pier-Luigi Lollini, Stefania Croci, Annalisa Astolfi, Kazuo Shin-ya, Lorena Landuzzi, Barbara Seliger, Giordano Nicoletti, Carla De Giovanni, Arianna Palladini
2010-09-01

Immunoprevention and immunotherapy of mammary carcinoma

Pier-Luigi Lollini, Patrizia Nanni, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni
2009-05-20

Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells

Stefania Croci, Gabriella Campadelli-Fiume, Patrizia Nanni, Pier-Luigi Lollini, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Laura Menotti
2009-11-01

Molecular and cellular biology of rhabdomyosarcoma

Lorena Landuzzi, Pier-Luigi Lollini, Patrizia Nanni, Giordano Nicoletti, Carla De Giovanni
2009-01-31

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

Manuela Iezzi, Patrizia Nanni, Pier-Luigi Lollini, Stefania Croci, Marianna L Ianzano, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Annalisa Murgo, Arianna Palladini, Valeria Stivani, Valentina Grosso, Piero Musiani, Agnese Antognoli
2009-04-01

Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4.

Patrizia Nanni, Pier-Luigi Lollini, Stefania Croci, Annalisa Astolfi, Marianna L Ianzano, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Annalisa Murgo, Arianna Palladini, Valeria Stivani, Agnese Antognoli
2009-12-22

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy

Patrizia Nanni, Pier-Luigi Lollini, Stefania Croci, Agnese Antognoli, Katia Scotlandi, Marianna L Ianzano, Lorena Landuzzi, Giordano Nicoletti, Carlos Garcia-Echeverria, Carla De Giovanni, Annalisa Murgo, Arianna Palladini, Valeria Stivani, Valentina Grosso
2007-11-01

Antimetastatic activity of a preventive cancer vaccine

Patrizia Nanni, Stefania Croci, Agnese Antognoli, Silvano Ferrini, Manuela Iezzi, Pier-Luigi Lollini, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Annalisa Murgo, Arianna Palladini, Piero Musiani
2007-07-01

Inhibition of prostate carcinogenesis by combined active immunoprophylaxis

Pier-Luigi Lollini, Patrizia Nanni, Stefania Croci, Manuela Iezzi, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Arianna Palladini, Tania Pannellini, Piero Musiani, Emma Di Carlo
2006-01-24

Endothelin-3 production by human rhabdomyosarcoma: a possible new marker with a paracrine role

Pier-Luigi Lollini, Patrizia Nanni, Stefania Croci, Annalisa Astolfi, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Arianna Palladini, Angelo Rosolen
2005-02

Cancer immunoprevention

Patrizia Nanni, Pier-Luigi Lollini, Carla De Giovanni, Tania Pannellini
2005-02-03

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.

Patrizia Nanni, Elena Quaglino, Manuela Iezzi, Pier-Luigi Lollini, Federica Cavallo, Raffaele A. Calogero, Simona Rolla, Annalisa Astolfi, Carla De Giovanni, Piero Musiani
2004-11-01

Immunological prevention of a multigene cancer syndrome

Patrizia Nanni, Pier-Luigi Lollini, Stefania Croci, Annalisa Astolfi, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Piero Musiani, Emma Di Carlo
2004-03-01

Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells

Patrizia Nanni, Pier-Luigi Lollini, Stefania Croci, Annalisa Astolfi, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Angelo Rosolen
2004-03-01

Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity

Patrizia Nanni, Pier-Luigi Lollini, Stefania Croci, Annalisa Astolfi, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni

Human - wd:Q91405927

Welcome to Inventaire

the library of your friends and communities

learn more